Kiniksa Pharmaceuticals
KNSA
KNSA
56 hedge funds and large institutions have $295M invested in Kiniksa Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 31 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
24% less capital invested
Capital invested by funds: $385M → $295M (-$90.6M)
Holders
56
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$29.1M | |
| 2 | +$10.4M | |
| 3 | +$8.07M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.1M |
| 5 |
BlackRock
New York
|
+$5.83M |
Top Sellers
| 1 | -$10.1M | |
| 2 | -$1.36M | |
| 3 | -$1.25M | |
| 4 |
AG
Algert Global
San Francisco,
California
|
-$300K |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$247K |